The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Is Meta Platforms Stock a Buy on the Dip as Revenue Surges? Meta's quarterly results were much better than some reports would have you believe.
Could You Retire With Less Than $1 Million? Millions of People Do. One study suggests that the typical retiree has only $126,000 in household savings.
Where Will Mastercard Stock Be in 5 Years? No hyperscaler-sized AI buildout, no capital-spending drama -- just a payments network compounding in the teens. What is that worth by 2031?
If I Were in My 20s, I'd Buy This Magnificent ETF and Hold It Until Retirement Young investors can build significant wealth in the stock market by focusing on the long term.
What Does Planet Labs CFO Ashley Johnson's Sale of Shares Worth $2.4 Million Mean for Investors? The Earth-imaging satellite data provider reported a notable insider sale following a 226% one-year stock surge.
A GlobalFoundries Director Sold Ahead of Earnings. Here's What Long-Term Investors Should Know This insider sale follows a volatile stretch for the stock, which is nonetheless up about 40% this past year.
What Nvidia Could Be Worth on a $1,000 Investment if History Repeats Itself Nvidia could still deliver impressive gains if Wall Street keeps raising its earnings estimates.
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000.
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock The company is on the verge of becoming a commercial-stage biotech, with two promising therapies in phase 3 trials.
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238.
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.
Is Arm Holdings Stock a Buy on the Bullish CPU Outlook? The company is now more confident in hitting its near-term CPU target.
3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026 As stocks pull back from recent highs, lean into these three blue chip dividend stocks.
Why This Business First Insider Sale Matters Less Than Second-Half Loan Growth And Deposits Keith Mansfield's transaction reduced his direct equity stake by 5%, though he retains 77,139 shares and 13,374 restricted stock units vesting through 2029.
What This Business First Insider Sale Signals After a 34% Stock Run George W. Iii Cummings reduced his stake by 8% while the stock posted a 34% one-year return, leaving him with ~225,000 shares and a 0.69% ownership position.
Aehr Test Systems vs. C3.ai: Which Technology Stock Is a Better Buy in 2026? Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.
IonQ vs. Rigetti: Which Quantum Computing Stock Is a Better Buy in 2026? IonQ is scaling with 201% revenue growth and a domestic semiconductor play, while Rigetti faces revenue headwinds and capital constraints.
Why Sprouts Farmers Market Stock Surged This Week The grocer is well-positioned to benefit from the trend toward eating healthy food at home.
Micron Technology Stock Is Plummeting, but Here's Why I'm Not Buying the Dip Investors are increasingly nervous about the sustainability of the artificial intelligence spending boom.
What if I Have $2 Million Saved for Retirement? Is It Really Enough to Stop Working? A $2 million nest egg may seem as if it will leave you with plenty of money, but that isn't necessarily the case.
Bloom Energy vs. Oklo: Which Power Stock Is a Better Buy in 2026? One sells power today with $2B in revenue and major partnerships; the other has zero revenue but billion-dollar customer commitments.
Why Teva Pharmaceutical Stock Surged This Week Teva reported its Q2 results this week, but the stock's big gains mostly stemmed from another catalyst.
3 Reasons Why Berkshire Hathaway Owns $29 Billion of Alphabet Stock Even if Alphabet is worth $4.1 trillion, Berkshire's investments indicate it sees it as undervalued.
As Cloud Revenue Soars, Is It Time to Buy Microsoft Stock? Microsoft's stock still looks attractive after its recent price jump.
ASML vs. TSMC: Which Semiconductor Supply Chain Stock Is the Better AI Play? Both companies play important roles in the building boom from artificial intelligence.
American Express: The Growth Story Isn't Over (NYSE: AXP) The purveyor of premium credit cards will see its revenue and earnings continue to increase over time.
3 Bold Oil Predictions for the Second Half of 2026 The geopolitical conflict in the Middle East is raging again, leaving investors in an uncertain position... again.
Is It Too Late to Buy Bloom Energy? My Honest Take. Bloom Energy's stock price was cut in half. Now it might soar again.
3 Ultra-High-Yield Energy Stocks to Hold Forever The S&P 500 index yields 1%, while these three energy stocks yield up to 5%.
3 Reasons to Buy Reddit Stock in August This stock is down nearly 40% this year, but you don't have to fix what isn't broken.
Is Solana (SOL) a Buy Right Now? Will the developer-driven token bounce back this year?
Nobody's Talking About the 1 Biggest Risk Facing Nvidia With a share price that has climbed more than 130-fold in a decade, it can be a challenge to focus on the downside.
IonQ vs. D-Wave Quantum: Which Quantum Computing Stock Is a Better Buy in 2026? Both companies are burning cash and unprofitable, but their technology bets and customer rosters tell a starkly different story.
Archer Aviation vs. Delta Air Lines: Which Industrials Stock Is a Better Buy in 2026? One funds electric air taxis with a $1.5 billion airline order; the other generates $3.8 billion in annual free cash flow.
Microsoft vs. Meta Platforms: Which Is the Better Magnificent Seven Stock to Buy Right Now? Investors looking to add one of these tech giants to their portfolios have an easy decision to make.
Your 12-Months-Till-Retirement Countdown: 5 Crucial Moves to Make. Check all of these off your list to approach retirement with more confidence.
Prediction: Western Digital Gets Back to Its High Before Sandisk Gets Back to Its Own. Two storage stocks surged together last week. Their paths back to record highs are nothing alike.
The Bond Market Just Called Fed Chair Kevin Warsh's Bluff on Interest Rates Bond traders aren't counting on Warsh and the Federal Open Market Committee (FOMC) to sit on their proverbial hands for much longer.
BigBear.ai vs. D-Wave Quantum: Which Technology Stock Is a Better Buy in 2026? One is profitable on paper but faces accounting restatements; the other burns cash but claims triple-digit growth.
Microsoft vs. Apple: Comparing Revenue Trends and the Impact of Artificial Intelligence Microsoft's revenue has climbed steadily while Apple's swings wildly with the calendar — but the gap between them is narrowing.
Plug Power vs. Occidental Petroleum: Which Energy Stock Is a Better Buy in 2026? One generates billions in free cash flow but faces commodity volatility; the other burns cash while betting on hydrogen's future.
Advanced Micro Devices vs. Arm: Which Tech Stock Is a Better Buy in 2026? One builds the chips; the other licenses the blueprint. Their vastly different business models and risk profiles demand different investor strategies.
Is Apple Stock a Buy on the Dip as iPhone Sales Surge? Buying the dip in Apple's stock may be tempting, but I'd hold off.
IonQ vs. Alphabet: What Revenue Trends Reveal About the Quantum Computing Chipmaker and the Artificial Intelligence Giant IonQ's revenue has tripled in two years, yet Alphabet still generates 1,700 times more per quarter — a gap that defines the quantum computing bet.
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? Abbott trades at half Lilly's valuation multiple, but Lilly's 45% revenue surge and 32% net margin raise the stakes for growth-focused investors.
